These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 23808800)
41. De Novo Malignancies After Liver Transplantation: Experience of a High-Volume Center. Saglam K; Sahin TT; Ogut Z; Ince V; Usta S; Yilmaz S J Gastrointest Cancer; 2022 Dec; 53(4):1020-1027. PubMed ID: 34778909 [TBL] [Abstract][Full Text] [Related]
42. De Novo Malignancies After Liver Transplantation With 14 Cases at a Single Center. Liu ZN; Wang WT; Yan LN; Transplant Proc; 2015 Oct; 47(8):2483-7. PubMed ID: 26518956 [TBL] [Abstract][Full Text] [Related]
43. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation. Hoffmann CJ; Subramanian AK; Cameron AM; Engels EA Transplantation; 2008 Sep; 86(6):784-90. PubMed ID: 18813102 [TBL] [Abstract][Full Text] [Related]
44. A Comparative Review of Standardized Incidence Ratios of De Novo Malignancies Post Liver Transplantation in Males Versus Females. Waldron O; Kim A; Daoud D; Zhu J; Patel J; Butler T; Zhou S; Jain A Transplant Proc; 2024; 56(6):1365-1373. PubMed ID: 39003208 [TBL] [Abstract][Full Text] [Related]
45. De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008. Ettorre GM; Piselli P; Galatioto L; Rendina M; Nudo F; Sforza D; Miglioresi L; Fantola G; Cimaglia C; Vennarecci G; Vizzini GB; Di Leo A; Rossi M; Tisone G; Zamboni F; Santoro R; Agresta A; Puro V; Serraino D Transplant Proc; 2013 Sep; 45(7):2729-32. PubMed ID: 24034034 [TBL] [Abstract][Full Text] [Related]
47. De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Herrero JI; Lorenzo M; Quiroga J; Sangro B; Pardo F; Rotellar F; Alvarez-Cienfuegos J; Prieto J Liver Transpl; 2005 Jan; 11(1):89-97. PubMed ID: 15690541 [TBL] [Abstract][Full Text] [Related]
48. Incidence and survival rate of de novo tumors in liver transplants. Bernal Bellido C; Suárez Artacho G; Álamo Martínez JM; Marin Gómez LM; Cepeda Franco C; Barrera Pulido L; Praena Fernández JM; Padillo Ruiz J; Gómez Bravo MÁ Cir Esp (Engl Ed); 2018 Oct; 96(8):501-507. PubMed ID: 30017062 [TBL] [Abstract][Full Text] [Related]
49. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients. Bhat M; Mara K; Dierkhising R; Watt KDS Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826 [TBL] [Abstract][Full Text] [Related]
50. Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men. Maggi U; Consonni D; Manini MA; Gatti S; Cuccaro F; Donato F; Conte G; Bertazzi PA; Rossi G PLoS One; 2013; 8(6):e65238. PubMed ID: 23785414 [TBL] [Abstract][Full Text] [Related]
51. Incidence of de novo malignancy and all-cause mortality among heart transplant recipients. Barrera FJ; Mostofsky E; Salia S; Lehman L; Liou L; Mucci L; Mittleman MA Int J Cardiol; 2024 Nov; 415():132455. PubMed ID: 39153512 [TBL] [Abstract][Full Text] [Related]
52. De Novo Urological Malignancies After Renal Transplantation: An Asian 30-Year Experience. Lee HJ; Lim EJ; Woo SJQ; Aslim EJ; Ng LG; Gan VHL Clin Transplant; 2024 Jul; 38(7):e15415. PubMed ID: 39049619 [TBL] [Abstract][Full Text] [Related]
53. De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study. Kaneko J; Sugawara Y; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Yamashiki N; Kokudo N Transplantation; 2013 May; 95(9):1142-7. PubMed ID: 23572128 [TBL] [Abstract][Full Text] [Related]
54. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review. Salami A; Qureshi W; Kuriakose P; Moonka D; Yoshida A; Abouljoud M Transplant Proc; 2013; 45(1):315-9. PubMed ID: 23267811 [TBL] [Abstract][Full Text] [Related]
55. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients. Altieri M; Sérée O; Lobbedez T; Segol P; Abergel A; Blaizot X; Boillot O; Boudjema K; Coilly A; Conti F; Chazouillères O; Debette-Gratien M; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Kamar N; Latournerie M; Lebray P; Leroy V; Neau-Cransac M; Pageaux GP; Radenne S; Salamé E; Saliba F; Samuel D; Vanlemmens C; Besch C; Launoy G; Dumortier J Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101514. PubMed ID: 33714907 [TBL] [Abstract][Full Text] [Related]
56. Malignancy after kidney transplantation: results of 400 patients from a single center. Stratta P; Morellini V; Musetti C; Turello E; Palmieri D; Lazzarich E; Cena T; Magnani C Clin Transplant; 2008; 22(4):424-7. PubMed ID: 18312442 [TBL] [Abstract][Full Text] [Related]
57. De novo malignancies following liver transplantation: impact and recommendations. Herrero JI Liver Transpl; 2009 Nov; 15 Suppl 2():S90-4. PubMed ID: 19877025 [TBL] [Abstract][Full Text] [Related]
58. National survey of de novo malignancy after solid organ transplantation in Japan. Miyazaki T; Sato S; Kondo T; Kusaka M; Gotoh M; Saiki Y; Ono M; Kokudo N; Enosawa S; Satoh S; Soeda E; Furukawa H; Kobayashi E; Nagayasu T Surg Today; 2018 Jun; 48(6):618-624. PubMed ID: 29380136 [TBL] [Abstract][Full Text] [Related]
59. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study. Krynitz B; Edgren G; Lindelöf B; Baecklund E; Brattström C; Wilczek H; Smedby KE Int J Cancer; 2013 Mar; 132(6):1429-38. PubMed ID: 22886725 [TBL] [Abstract][Full Text] [Related]
60. Cancer incidence and mortality after heart transplantation - A population-based national cohort study. Jäämaa-Holmberg S; Salmela B; Lemström K; Pukkala E; Lommi J Acta Oncol; 2019 Jun; 58(6):859-863. PubMed ID: 30821595 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]